A Phase 1 Randomized, Placebo-controlled, Observer-blinded Trial to Evaluate the Safety and Immunogenicity of Inactivated Streptococcus pneumoniae Whole-cell Vaccine in Adults
Cheryl Keech, Mark R. Alderson(Program for Appropriate Technology in Health), Royce A. Morrison, David Goldblatt(Great Ormond Street Hospital), Porter Anderson(Boston Children's Hospital), John Hural(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Andrea Tate(Program for Appropriate Technology in Health), Jorge Flores(Program for Appropriate Technology in Health), David E. Briles(University of Alabama at Birmingham), Richard Malley(Boston Children's Hospital)
Cited by 30
Related Papers
HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysis
|The Lancet|2008|708
Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing
|Nature|1994|600
Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine
|New England Journal of Medicine|2013|586
Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition
|New England Journal of Medicine|2021|557
Interleukin-17A Mediates Acquired Immunity to Pneumococcal Colonization
|PLoS Pathogens|2008|492